1. Home
  2. GCT vs ALVO Comparison

GCT vs ALVO Comparison

Compare GCT & ALVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo GigaCloud Technology Inc

GCT

GigaCloud Technology Inc

HOLD

Current Price

$36.09

Market Cap

1.2B

ML Signal

HOLD

Logo Alvotech

ALVO

Alvotech

HOLD

Current Price

$3.06

Market Cap

1.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GCT
ALVO
Founded
2019
2013
Country
United States
Luxembourg
Employees
N/A
1460
Industry
Catalog/Specialty Distribution
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.2B
1.0B
IPO Year
2021
N/A

Fundamental Metrics

Financial Performance
Metric
GCT
ALVO
Price
$36.09
$3.06
Analyst Decision
Strong Buy
Buy
Analyst Count
1
4
Target Price
$33.00
$8.00
AVG Volume (30 Days)
621.1K
638.7K
Earning Date
05-08-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
17.70
N/A
EPS
1.04
N/A
Revenue
$1,161,042,000.00
N/A
Revenue This Year
$14.43
$13.28
Revenue Next Year
$6.78
$18.63
P/E Ratio
$34.40
$18.20
Revenue Growth
64.96
N/A
52 Week Low
$20.71
$2.94
52 Week High
$51.82
$9.94

Technical Indicators

Market Signals
Indicator
GCT
ALVO
Relative Strength Index (RSI) 52.78 35.84
Support Level $35.33 $2.99
Resistance Level $36.31 $3.94
Average True Range (ATR) 1.40 0.17
MACD 0.21 -0.03
Stochastic Oscillator 54.42 0.98

Price Performance

Historical Comparison
GCT
ALVO

About GCT GigaCloud Technology Inc

GigaCloud Technology Inc provides end-to-end and B2B e-commerce solutions for large parcel merchandise. Its B2B e-commerce platform, which is referred to as the GigaCloud Marketplace, integrates everything from discovery, payments, and logistics tools into one easy-to-use platform. It offers online and offline integrated cross-border transaction and delivery services for furniture and large merchandise. Its marketplace seamlessly connects manufacturers in Asia with resellers in the U.S., Asia, and Europe to execute cross-border transactions with confidence, speed, and efficiency. It offers a truly comprehensive solution that transports products from the manufacturer's warehouse to end customers, all at one fixed price. It earns the majority of its revenue from the United States.

About ALVO Alvotech

Alvotech is a biopharmaceutical company focused solely on the development and manufacture of biosimilar medicines for patients globally. Its purpose is to improve the health and quality of life of patients around the world by improving access to treatments for various diseases. The company's commercialized products incldue AVT02, AVT03, AVT04, AVT05, and AVT06. Its pipeline contains eight biosimilar candidates aimed at treating autoimmune disorders, eye disorders, osteoporosis, and cancer. Geographically, the company generates the majority of revenue from Europe, and the rest from the USA and the rest of the world.

Share on Social Networks: